Microwave-Assisted Synthesis and Antibacterial Activity of Some New Flavones and 1, 5-Benzothiazepines

 

VA Navale, SS Mokle, Archana Y Vibhute, KG Karamunge, SV Khansole, SB Junne and YB Vibhute*

P.G. Department of Chemistry, Yeshwant Mahavidyalaya, Nanded 431602 (M.S.) INDIA

*Corresponding Author E-mail:  drybv@rediffmail.com

 

ABSTRACT

The synthesis of heterocyclic compounds containing flavones (4a-i) and 1,5-benzothiazepines(5a-i) from chalcone derivatives containing 3,4-methylenedioxy phenyl ring using microwave irradiation in 80-97% yield within 2 – 4 min. The work-up is simple, shorter reaction time, increase in reaction rate with better yields. The structures of synthetic compounds have been characterized using IR and 1H NMR spectral data together with halogen analysis. All synthesized compounds have been screened for their antibacterial activity.

 

KEYWORDS:  Chalcones, flavones, 1,5-benzothiazepines, microwave irradiation, antibacterial activity.

 


 

INTRODUCTION:

Flavonoid compounds are a group of natural products found in fruits, vegetables, nuts, seeds and flowers as well as in teas and are important constituent of human diet. They have been demonstrated to posses antioxdidant1, antihypertensive2, antiallergic3, antinocicepative4, trypsin inhibitors5, antifeedant6, antibacterial and antifungal7, anti-infiammatory8 and antiproliferative9 activities. While 1,5-benzothiazepines also find a unique place in drug discovery programmes as they display a wide range of biological activities such as antibacterial10, anticancer11, analgesic12, antidibetic13, calcium antagonists14, anti-HIV15, endogenous natriuretic factors16 and as potential central nervous system agents.17

 

In the last few years microwave induced organic reaction enhancement (MORE) chemistry has gained popularity as a non-conventional technique for rapid organic synthesis18 and many researchers have described accelerated organic reactions, and a large number of papers has appeared. Proving the synthetic utility of MORE chemistry in routine organic synthesis19. It has been termed as ‘e-chemistry’ because it is easy, effective, economical and ecofriendly and is believed to be a step toward green chemistry. In view of these observations and in continuation of our work on biologically active heterocycles20, we have been planned to synthesize the new flavones (4a-i) and 1,5-benzothiazepines (5a-i) from chalcones (3a-i) and also studied their antibacterial activity.

 

The desired chalcones21,22 (3a-i) were synthesized by reacting reacting appropriate halo substituted 2-hydroxyacetophenones (1a-i) with pipernal (2) according to Claisen-Schmidt condensation. In typical case, flavones (4a-i) were prepared by oxidative cyclisation of chalcones (3a-i) using DMSO-I2 reagent under microwave irradiation. While equimolar quantities of chalcones (3a-i) and 2-amino thiophenol in acetic acid under microwave irradiation to obtain 1,5-benzothiazepines (5a-i).

 

Experimental:

All melting points are taken in open glass capillaries and were found uncorrected. The purity of compounds has been checked by TLC on silica gel G. The IR spectra in KBr were recorded on Shimadzu spectrophotometer and 1HNMR spectra were recorded in DMSO on Varian Inova 300 FT MHz spectrophotometer using TMS as internal standard (d ppm).

 

Synthesis of Flavones (4a-i):

Chalcone (0.001 mol) was suspended in DMSO (5 ml) and a crystal of iodine was added to it. The mixture was irradiated in a microwave oven (TLC) for 2-4 min. The progress of reaction was monitored after every 30 sec.of irradiation by TLC with petroleum ether: ethyl acetate (4:1 v/v mixture) as eluent. After each irradiation, the reaction mixture was cooled to room temperature and mixed well. After completion of the reaction (TLC), the solid mass was filtered off, washed with 20% sodium thiosulfate and recrystallised from aqueous ethyl alcohol to give compounds (4a-i).

 

 


Table 1: Physical and Analytical data of Flavones and 1,5-Benzothiazepines

Comp. Code

Mol.

formula

Mol.  Wight

Reaction

Period (min.)

M.P. (0OC)

Yield

(%)

Halogen Analysis

X (Cl,Br,I) % Found (Calcd.)

4a

C16H8O4Cl I

426.5

130

170

81

38.19 (38.10)

4b

C16H8O4 BrI

471

145

164

87

44.01 (43.94)

4c

C17H11O4I

406

155

166

93

31.19 (31.28)

4d

C17H11O4Br

359

170

182

82

22.34 (22.28)

4e

C16H8O4 I2

518

165

175

89

48.97 (49.03)

4f

C16H8O5 Br2

440

140

168

91

36.47 (36.36)

4g

C16H8O4 ClBr

379.5

125

186

84

30.49 (30.43)

4h

C17H10O4 BrCl

393.5

185

179

96

29.28 (29.35)

4i

C16H8O5 Cl2

351

150

159

85

20.30 (20.22)

5a

C22H15O3Cl INS

535.5

175

176

82

30.42 (30.34)

5b

C22H15O3BrINS

580

140

187

90

35.57 (35.68)

5c

C23H18O3INS

515

160

176

83

24.74 (24.66)

5d

C23H18O3BrNS

468

125

173

97

17.19 (17.09)

5e

C22H15O3I2NS

627

145

169

88

40.57 (40.51)

5f

C22H15O4Br2NS

549

175

199

81

29.02 (29.14)

5g

C22H15O3ClBrNS

488.5

150

177

85

22.34 (22.28)

5h

C23H17O3ClBrNS

502.5

180

210

94

23.07 (22.98)

5i

C22H15O4Cl2NS

381

145

189

85

18.71 (18.63)

 

 


Table 2: Antibacterial activity data of synthesized compounds

Compound code

Zone of inhibition (mm)

B. subtilis

E. coli

X. citri

E. carotovara

4a

17

15

20

19

4b

19

20

21

20

4c

12

15

12

10

4d

11

09

14

13

4e

21

20

19

18

4f

20

18

23

21

4g

18

16

16

18

4h

16

18

17

15

4i

24

23

25

24

5a

18

16

19

18

5b

19

18

20

19

5c

13

11

14

15

5d

11

10

15

13

5e

22

18

19

19

5f

23

21

20

22

5g

21

17

22

21

5h

19

18

20

19

5i

26

24

25

25

Tetracycline

100mg/ml

24

20

22

22

 

3’,4’-Methylenedioxy-6-methyl-8-iodoflavone (4c):

IR (KBr) cm-1: 1645(C=O), 1587, 1560 (ring C=C).

1HNMR (300 MHz, DMSO): δ7.18-8.20(m, 5H, Ar-H), 6.90 (s, 1H, COCH), 6.28(s, 2H, OCH2O) 2.53 (s, 3H, CH3).

 

3’,4’-Methylenedioxy-6,8-dibromo-7-hydroxyflavone (4f):

IR (KBr) cm-1: 3400(-OH), 1647(C=O), 1590, 1567 (ring C=C).

1HNMR (300 MHz, DMSO): δ10.65 (s, 1H, Ar-OH), δ7.10-8.05(m, 4H, Ar-H), 6.96 (s, 1H, COCH), 6.35(s, 2H, OCH2O).

 

Synthesis of 1,5-Benzothiazepines (5a-i):-

Chalcone (0.001 mol) and 2-amino thiophenol (0.001 mol) was dissolved in acetic acid (10ml). The mixture was irradiated in a microwave oven (TLC) for 2-4 min. The progress of reaction was monitored after every 30 sec. of irradiation by TLC petroleum ether/ethyl acetate (4:1 v/v mixture) as eluent. After each irradiation, the reaction mixture was cooled to room temperature and mixed well. After completion of the reaction (TLC), the solid mass was washed with water, dried and recrystallised from acetic acid to obtain pure (5a-i).

 

Synthesis of 2-(2-Benzo[1,3]dioxol-5-yl)-2,3-dihydro-4-(2’-hydroxy-3’-iodo-5’-methylphenyl)-1,5-benzothiazepine(5c):-

IR (KBr) cm-1: 3385(OH), 2950(saturated C-H), 1607(C=N), 1580, 1555 (ring C=C), 975, 760, 744.

1HNMR (300 MHz, DMSO): δ12.84 (s, 1H, 2-OH), 7.05-8.11(m, 9H, Ar-H), 6.25(s, 2H, OCH2O), 5.41(dd, 1H, HX), 3.45(dd, 1H, HB), 3.12(dd, 1H, HA), 2.61 (s, 3H, CH3).

 

Synthesis of 2-(2-Benzo[1,3]dioxol-5-yl)-2,3-dihydro-4-(2’4’-dihydroxy-3’,5’-dichlorophenyl)-1,5-benzothiazepine(5i):-

IR (KBr) cm-1: 3405(OH), 2943(saturated C-H), 1605(C=N), 1581, 1555 (ring C=C), 975, 765, 744.

1HNMR (300 MHz, DMSO): δ13.75(s, 1H, 2-OH), 10.84 (s, 1H, 4-OH), 7.0-8.15(m, 8H, Ar-H), 6.27(s, 2H, OCH2O), 5.36(dd, 1H, HX), 3.40(dd, 1H, HB), 3.15(dd, 1H, HA).

 

In vitro-antibacterial screening:-

The newly synthesized compounds were subjected to antibacterial screening by using cup plate diffusion method23 at 100mg/ml concentration. The antibacterial activity was tested against Escherichia coli, Bacillus subtilis, Xanthomanas citri and Ervinia carotovara using Tetracycline as standard antibiotic. The zone of inhibition was measured using mm scale.

 

CONCLUSION:

In conclusion, we have synthesized some new flavones and 1,5-benzothiazepines from chalcones under microwave irradiation. Shorter reaction time, simple reaction condition, easy work-up and higher yield render this method superior. From the antibacterial screening it was observed that all compounds exhibited antibacterial activity against all organisms employed. Compound number 4e, 4f, 4i, 5e, 5f, 5g and 5i showed greater or nearly same antibacterial activity than standard drug Tetracycline, where as other compounds showed moderate to good activity.

 

ACKNOWLEDGEMENT:

Authors are also grateful to UGC New Delhi for sanctioning Major Research Grant and the Director, IICT, Hyderabad for spectral analysis.The authors are also express their sincere thanks to Principal, Yeshwant Mahavidyalaya, Nanded (M.S.) and Head, Department of Biotechnology, Yeshwant Mahavidyalaya, Nanded (M.S.)India for providing the necessary facilities during this work.

 

REFERENCES:

1.        Yoo H, Kim SH, Lee J, Kim HJ, Seo SH, Chung BY, Jin C and Lee YS, Bull.Korean Chem.Soc. 2005; 26(12):2057-2060.

2.        Li JX, Xub B, Chai Q, Liu ZX, Zhao AP and Chan LB, Chin.J.Physiol. 2005; 48: 101-106.

3.        Inoue T, Sugimoto Y, Masuda H and Kamei C, Biol.Pharm.Bull. 2002; 25: 256-259.

4.        Umamaheswari S, Viswanathan S, Sathiyasekaran BWC, Parvathavarthini S and Ramaswamy S, Indian J.Pharm.Sci. 2006; 68(6): 749-753.

5.        Maliar T, Jedinak A, Kadrabova J and Sturdik E. Structural Aspects of Flavonoids as Trypsin Inhibitors, Eur.J.Med.Chem. 2004; 39: 241-248.

6.        Morimoto M, Tanimoto K, Nakano S, Ozaki T, Nakano A and Komai K, J. Agri.Food.Chem. 2003; 51: 389-393.

7.        Mostahar S, Katun P and Islam A, J.Biol.Sci. 2007; 7(3): 514-519.

8.        Kim JY, Lim HJ and Ryu J-H,  Bioorg.Med.Chem.Lett. 2008; 18: 1511-1514.

9.        Pouget C, Lauthier F, Simon A, Fagnere C, Basly J-P, Delage C and Chulia A, 2001; 11: 3095-3097.

10.     Karale K, Chavan VP, Mane AS, Hangarge RV, Gill CH and Shingyare MS, Korean J. of Med.Chem. 2002; 10(2): 84.

11.     McGee MM, Gemma S, Butini S, Ramunno A, Zisterer DM, Fattorusso C, Catalanotti B, Kukreja G, Fiorini I, Pisano C, Cucco C, Novellino E, Nacci V, Willaims DC and Campiani G, J.Med.Chem. 2005; 48: 4367.

12.     Satyanarayanan K and Rao MN, Indian J.Pharm. Sci. 1993; 55: 230.

13.     Avram S, Milac A-L and Flonta ML, Curr. Computer-Aided Drug Design 2005; 1: 347.

14.     Chaffman M, and Brogden RN, Drugs 1985; 29: 387.

15.     Grandolini G, Perioli L and Ambrogi V, Eur.J.Med.Chem. 1999; 34: 701.

16.     Kontoci D, Murray ED, Quiggle DD and Wechter WJ, J.Med.Chem. 1996; 39: 1196.

17.     Liegeois JFF, Rogister  FA, Bruchwyler J, Damas J, Nguyen TP, Inarejos MO, Chleide, Mercier MAG and Delarge JE, J.Med.Chem. 1994; 37: 519.

18.     Varma S, Green Chemistry 1999; 1:43.

19.     Kidwai M, Dare B and Venkatarmana R, Ind. J.Chem. 2002; 41B: 2414.

20.     a) Vibhute YB and Basser MA, J.Indian Chem.Soc.2001; 78: 319. b) Mokle SS, Sayyed MA, Kothawar and Chopde, Int. J. Chem. Sci. 2004; 2(1): 96. c) Mokle SS, Sayyed MA, Bhusare SR, Pawar RP and Vibhute YB, Chemistry: An Indian Journal 2005; 2(9): 302-305. d) Sayyed MA, Mokle SS, Bokhare MV, Mankar AN, Surwase SM, Shusare SR and Vibhute YB, ARKIVOC, 2006; General papers (part II): 187. e) Sayyed MA, Mokle SS and Vibhute YB, ARKIVOC, 2006; xi: 221. f) Sayyed MA, Nalwar YS, Mokle SS, Vibhute AY, Khansole SV and Vibhute YB, Int.J.ChemTech Res., 2009; 1(3): 606.

21.     Karamunge K.G.,Thesis submitted to Swami Ramanand Teerth Marathwada University, Nanded (MS)INDIA.

22.     Karamunge K.G., Vibhute A.Y., Junne S.B., Sayyed M.A. and Vibhute Y.B., J.Indian Chem.Soc.(accepted).

23.     Collins CH. Microbiological Methods. London: Buterworths; 1967.

 

 

 

 

Received on 22.07.2009        Modified on 17.09.2009

Accepted on 10.10.2009        © AJRC All right reserved

Asian J. Research Chem. 2(4):Oct.-Dec. 2009 page 472-475